Health Care Costs and Medication Adherence Associated with Initiation of Insulin Pen Therapy in Medicaid-Enrolled Patients with Type 2 Diabetes: A Retrospective Database Analysis
Clinical TherapeuticsPublished 1 January 2007
Manjiri Pawaskar, Fabian Camacho, Roger T. Anderson, D Cobden, Ashish V. Joshi, Rajesh Balkrishnan
Citations112
SJR quartileQ1
SJR score0.98
SNIP1.02
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In a state Medicaid setting among patients with type 2 diabetes, initiating insulin therapy with a pen device was associated with comparable medication adherence and significant reductions in health care resource utilization and associated costs compared with vial/syringe insulin.
Abstract
In a state Medicaid setting among patients with type 2 diabetes, initiating insulin therapy with a pen device was associated with comparable medication adherence and significant reductions in health care resource utilization and associated costs compared with vial/syringe insulin. Health care professionals and policy makers should consider the potential economic benefits of pen therapy when initiating insulin among Medicaid beneficiaries who fail to respond to oral antidiabetic drugs.
Keywords
Medicine
BiometrikaThe central role of the propensity score in observational studies for causal effects
30,963 Citations1983Paul R. Rosenbaum, Donald B. Rubin
Statistics in MedicinePropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
5,302 Citations1998Ralph B. D’Agostino
This tutorial discusses the uses of propensity score methods for bias reduction, gives references to the literature and illustrates the uses through applied examples.
JAMAActual Causes of Death in the United States, 2000
5,213 Citations2004Ali H. Mokdad
These analyses show that smoking remains the leading cause of mortality in the United States, however, poor diet and physical inactivity may soon overtake tobacco as the lead cause of death.
Diabetes CareEconomic Costs of Diabetes in the U.S. in 2002
4,170 Citations2003Paul Hogan, Timothy M. Dall +1 more
The estimated 132 billion US dollars cost of diabetes likely underestimates the true burden of diabetes because it omits intangibles, such as pain and suffering, care provided by nonpaid caregivers, and several areas of health care spending where people with diabetes probably use services at higher rates than people without diabetes.
Annals of Internal MedicinePharmacologic Therapy for Type 2 Diabetes Mellitus
1,175 Citations1999Ralph A. DeFronzo
These findings provide unequivocal evidence for hepatic resistance to insulin, and this evidence is substantiated by an impaired ability of insulin to suppress hepatic glucose production, which is the major determinant of the mean day-long blood glucose level.
Diabetes CareStandards of Medical Care in Diabetes–2006
1,104 Citations2006Kingston H. Tseng
In regard to the ADA’s recommendation to use statin therapy for diabetic patients without overt cardiovascular disease (CVD), the recommendation to treat “regardless of baseline LDL” might have extended beyond the evidence quoted.
Diabetes CareGlycemic Control From 1988 to 2000 Among U.S. Adults Diagnosed With Type 2 Diabetes
654 Citations2004Carol E. Koro, Steven J. Bowlin +2 more
The changes in demographics, antidiabetic treatment, and glycemic control among the prevalent U.S. adult diagnosed type 2 diabetes population between the National Health and Nutrition Examination Survey (NHANES) III and the initial release of NHANES 1999-2000 are described.
Diabetes CareLess nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
582 Citations2000Hannele Yki‐Järvinen, A. Dressler +2 more
Use of insulin glargine instead of NPH in insulin combination regimens in type 2 diabetes is associated with less nocturnal hypoglycemia and lower post-dinner glucose levels, consistent with peakless and longer duration of action of insulinglargine compared with NPH.
BiometrikaAn omnibus test of normality for moderate and large size samples
547 Citations1971Ralph B. D’Agostino
The LancetAdherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus
509 Citations1997Andrew D. Morris, Douglas Boyle +4 more
It is suggested that poor adherence to insulin treatment is the major factor that contributes to long-term poor glycaemic control and diabetic ketoacidosis in patients aged 10-20 years.
Medical CareA General Method of Compliance Assessment Using Centralized Pharmacy Records
461 Citations1988John F. Steiner, Thomas D. Koepsell +2 more
It is concluded that the method of assessing compliance in obtaining medications is feasible in “managed care” settings, appears to be a valid correlate of drug effects, and may be useful in research and patient care.
International Journal of ObesityWhen oral agents fail: practical barriers to starting insulin
450 Citations2002Mary T. Korytkowski
It is essential that obstacles to the initiation of insulin therapy are identified and investigated as a means of overcoming these impediments to recommended levels of glycaemic control and address psychological insulin resistance.
Diabetes CareA randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
450 Citations1999Rury R. Holman, C A Cull +1 more
Acarbose significantly improved glycemic control over 3 years in patients with established type 2 diabetes, irrespective of concomitant therapy for diabetes.
Diabetes CareClinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes
404 Citations2004Manel Pladevall, L. Keoki Williams +4 more
Claims-based measures of medication adherence are associated with clinical outcomes in patients with diabetes and may therefore prove to be useful in clinical practice and more research is needed on methods to introduce claims-based adherence measurements into routine clinical practice.
Diabetes CareThe Association Between Diabetes Metabolic Control and Drug Adherence in an Indigent Population
376 Citations2002Joel M. Schectman, Mohan Nadkarni +1 more
Great efforts are clearly needed to facilitate diabetes self-management behaviors of low-income populations and foster culturally sensitive and appropriate care for minority groups, as African-Americans have lower adherence and worse metabolic control.
PubMedNeedle phobia: a neglected diagnosis.
374 Citations1995James G. Hamilton
In a family practice, needle phobia can be managed by reassurance and education, avoidance of needles, postural and muscle tension techniques, benzodiazepines, nitrous oxide gas, and topical anesthesia applied by iontophoresis.
The Diabetes EducatorPatient Adherence Improves Glycemic Control
344 Citations2005Mary K. Rhee, Wrenn Slocum +7 more
Keeping more appointments and taking diabetes medications as directed were associated with substantial improvements in HbA1c, and efforts to enhance glycemic outcomes should include emphasis on these simple but critically important aspects of patient adherence.
New England Journal of MedicineComparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes Mellitus
327 Citations1992Hannele Yki‐Järvinen, Marjut Kauppila +12 more
It is suggested that patients with NIDDM do not benefit from multiple insulin injections and that nocturnal insulin administration appears preferable to daytime administration, and glycemic control is improved in a manner similar to combination therapy with NPH insulin in the morning, a two-insulin-injection regimen, but induces less weight gain and hyperinsulinemia.
Diabetes CareNIDDM Patients' Fears and Hopes About Insulin Therapy: The basis of patient reluctance
273 Citations1997Linda M. Hunt, Miguel A. Valenzuela +1 more
Patients' positive attitudes toward insulin focus on its efficacy and efficiency, the avoidance of complications, and feeling better and more energetic, indicating that these themes may be generally applicable to a wider population.
Clinical TherapeuticsMedication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
262 Citations2006Won Chan Lee, Sanjeev Balu +3 more
Among patients with type 2 diabetes treated in a managed care setting, a switch from administration of insulin therapy by vial/syringe to a prefilled insulin analogue pen device was associated with improved medication adherence, fewer claims for hypoglycemic events, reduced emergency department and physician visits, and lower annual treatment costs.
PubMedOral agents in the management of type 2 diabetes mellitus.
146 Citations2001Beatriz Luna, Mark N. Feinglos
In patients for whom diet and exercise do not provide adequate glucose control, therapy with a single oral agent can be tried and a combination of agents with different mechanisms of action may have additive therapeutic effects and result in better glycemic control.
Clinical DiabetesWhat's So Tough About Taking Insulin? Addressing the Problem of Psychological Insulin Resistance in Type 2 Diabetes
133 Citations2004William H. Polonsky, Richard A. Jackson
Qualitative data from Hunt et al. suggest that PIR may be common in the Hispanic population, and surveys of insulin-naive type 2 patients suggest that Hispanic patients were much more frequently unwilling to take insulin if it was prescribed.
Clinical TherapeuticsFlexPen®: Addressing issues of confidence andconvenience in insulin delivery
121 Citations2005Mary T. Korytkowski, Leo Niskanen +1 more
Insulin pen devices are discreet and offer patients convenience and flexibility, which may give patients the confidence to overcome issues of needle anxiety and the social embarrassment associated with self-injection and, therefore, may lead to improved adherence to recommended insulin dosing schedules and compliance with multiple- injection regimens.
PubMedCosts and utilization associated with pharmaceutical adherence in a diabetic population.
120 Citations2004Kera L Hepke, M. Martus +1 more
Increased adherence with pharmaceutical therapy was associated with decreased use of medical care services, suggesting improved disease control and well being, but not with lower costs.
Age and AgeingA systematic review of the effectiveness of interventions to help older people adhere to medication regimes
98 Citations2004Niall Higgins
There is no strong evidence to support the use of any one intervention type for adherence to medication for older people over the age of 65, and future research should use combinations of approaches, as there is some evidence that these are more likely to be successful.
International Journal of ObesityThe reality of glycaemic control in insulin treated diabetes: defining the clinical challenges
91 Citations2004Melanie J. Davies
There is a limit to what can be achieved with existing exogenous insulin therapies due to their imperfect pharmacokinetic and pharmacodynamic profiles, and the problem of variability of effect from injection to injection with basal insulin formulations.
Diabetes/Metabolism Research and ReviewsThe underuse of insulin therapy in North America
91 Citations2002Matthew C. Riddle
Promising new patterns of insulin use in type 2 patients are emerging in the US: the availability of insulin as a single dose, rather than moving directly to multiple daily injections; the practice of continuing rather than stopping oral agents when an evening insulin dose is added; and the use of new insulins and insulin‐sensitizing agents that facilitate therapy and increase its effectiveness.
Diabetes SpectrumImproving Adherence to Diabetes Self-Management Recommendations
66 Citations2002Clyde B. Schechter, Elizabeth A. Walker
A wide variety of educational, behavioral, and affective interventions are available that individually produce modest improvements in patient adherence to treatment recommendations in diabetes and related chronic illnesses and that work somewhat better when used in combination.
Diabetes Research and Clinical PracticeInsulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations
64 Citations1990Jan Olof Hörnquist, Anders Wikby +2 more
The pen contributes to a better life for the IDDM patient and the quality of life changes due to treatment intervention appear to be assessable, corroborated by recent studies with other designs and methods.
The Diabetes EducatorA Comparison of Insulin Pen Use in the United States and the United Kingdom
59 Citations2002Sara Costa, Betty Brackenridge +1 more
It is suggested that pen delivery systems are an option that should be routinely offered to all insulin users and hold the potential to promote improved blood glucose control and thus reduce the risk of the chronic complications of diabetes.
Diabetic MedicineTreatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients
49 Citations2003M.‐J. J. Pouwels, Cees J. Tack +2 more
This investigation investigated whether a period of euglycaemia using i.v. insulin, followed by continuous subcutaneous insulin infusion (CSII), would ameliorate the deleterious effects of hyperglycaemia on insulin sensitivity and result in sustained, improved metabolic control.
Clinical cornerstoneOvercoming psychological barriers to insulin use in type 2 diabetes
47 Citations2006Stephen Brunton, Stephen N. Davis +1 more
The subject of insulin therapy should be approached positively and should be presented as an effective and flexible way to achieve glycemic goals for any patient at any time during therapy.
International Journal of ObesityBefore oral agents fail: the case for starting insulin early
44 Citations2002Michel Marre
The use of premixed insulin analogues in combination with OHAs allows effective postprandial glucose control, a twice-daily injection regimen and a short meal-injection interval.
Journal of Diabetes and its ComplicationsEffect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2
25 Citations2004Daniel Antonio de Luis, R. Aller +5 more
Innolet improved glycemic control and satisfaction in a group of elderly patients with diabetes mellitus type 2 previously treated with pen devices.
Advances in pharmacologyClinical Studies
23 Citations2005Andrew Young
Pramlintide co-therapy was a first-in-class drug development program that ultimately led to marketing approval by the U.S. Food and Drug Administration of the amylinomimetic pramlintide acetate in March 2005, and the prescribers' package insert, which includes a synopsis of safety and efficacy of pramlints, is included as Appendix 1.
The American Journal of MedicineHow to select and combine oral agents for patients with type 2 diabetes mellitus
17 Citations2005Stuart R. Chipkin
It is demonstrated that combination therapy is more likely than monotherapy to achieve glucose control in patients not at glycemic targets, and adding a new agent to an existing regimen is typically better than using the new agent as monotherapy.
Humana Press eBooksBarriers to Treatment
17 Citations2005Arthur L. Frank
For almost all overweight people, the traditional medical care system is irrelevant for the management of their problem, and its treatment has traditionally followed a format outside the typical care patterns of other chronic diseases.
PubMedCurrent treatment approaches to type 2 diabetes mellitus: successes and shortcomings.
17 Citations2002Francis M Collins
An antidiabetic agent that improves insulin sensitivity is an excellent choice for early treatment of type 2 diabetes because it may delay or prevent complications associated with this disease.
Diabetes CareInsulin Treatment and Type 1 Diabetes Topics
11 Citations2006Zachary T. Bloomgarden
In a study of 619 persons with type 1 diabetes, insulin glargine given at bedtime was associated with lower fasting glucose and with lower variability in fasting glucose level than NPH insulin given …
Treatments in EndocrinologyIs There a Rationale for Insulin Therapy in Pre-Diabetic Individuals?
7 Citations2006Sherwyn Schwartz
Initial results from a small study have indicated the feasibility of treating individuals with pre-diabetes to near-normoglycemia using a regimen of low-dose insulin glargine plus caloric restriction, and this is being followed up in the ongoing ORIGIN (Outcomes Reduction with Initial Glargine INtervention) study, which will investigate the potential benefits of insulin therapy.
BMJDiabetes a growing problem in United States
5 Citations2001Janice Hopkins Tanne
The United States, like many other industrialised countries, faces a diabetes epidemic, and one third of them don't even realise it, says Dr Susan Hershberg Adelman, a trustee of the American Medical Association.
Europe PMC (PubMed Central)Diabetes a growing problem in United States
2 Citations2001Hopkins, Janice